<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03211442</url>
  </required_header>
  <id_info>
    <org_study_id>RT2017-08</org_study_id>
    <nct_id>NCT03211442</nct_id>
  </id_info>
  <brief_title>Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events</brief_title>
  <acronym>MEDIRAD-BRACE</acronym>
  <official_title>Implications of MEDIcal Low Dose RADiation Exposure - BReast Cancer Acute Coronary Events (MEDIRAD-BRACE): A Retrospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stichting het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum rechts der Isar der Technischen Universität München</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut de Radioprotection et de Sûreté Nucléaire</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Medical Center Groningen</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      MEDIRAD-BRACE aims to determine the relationship between 3D dose distributions in cardiac
      structures and the risk of acute coronary events (ACE) and other cardiac complications in
      breast cancer (BC) patients to develop and externally validate multivariable Normal Tissue
      Complication Probability (NTCP) models to assess the risk of ACE in individual patients based
      on cardiac dose metrics in the first 10 years after BC radiotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">November 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with an Acute Coronary Event after completion of RT treatment</measure>
    <time_frame>First 10 years after RT treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with other cardiac complications after completion of RT treatment</measure>
    <time_frame>First 10 years after RT treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with radiotherapy-induced late non-cardiac toxicity (e.g. secondary tumors)</measure>
    <time_frame>First 10 years after RT treatment</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">7000</enrollment>
  <condition>Breast Cancer Female</condition>
  <condition>Acute Coronary Events</condition>
  <condition>Cardiac Complications</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiotherapy</intervention_name>
    <description>Breast cancer patients treated with radiotherapy</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult, female patients with stage I-III breast cancer, treated with primary surgery, either
        by mastectomy of breast conserving surgery, and postoperative RT in the period 2005-2013,
        and who were aged 40-75 years at the time of RT
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female breast cancer patients;

          -  Treated with primary surgery for stage I-III invasive adenocarcinoma of the breast or
             ductal carcinoma in situ (DCIS);

          -  Age between 40-75 years at time of start RT;

          -  WHO performance status 0-1;

          -  Planned for RT alone to the breast, the chest wall and/or the lymph node areas;

          -  Start of RT is between 01-01-2015 and 31-12-2013;

          -  Available planning CT scan and dose distribution;

          -  Adjuvant systemic treatment, including hormonal therapy or chemotherapy is allowed;

          -  Medical history of coronary artery disease and/or myocardial infarction is not an
             exclusion criterion;

          -  Written informed consent.

        Exclusion Criteria:

          -  Male breast cancer patients;

          -  Women with metastatic breast cancer (M1 disease);

          -  Any prior malignancy other than non-melanoma skin cancer;

          -  Previous thoracic or mediastinal radiation;

          -  Women treated with neoadjuvant chemotherapy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>A.P.G. Crijns, Dr.</last_name>
    <phone>+31503615532</phone>
    <email>a.p.g.crijns@umcg.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A.P.G. Crijns, Dr.</last_name>
      <phone>+31503615532</phone>
      <email>a.p.g.crijns@umcg.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2017</study_first_submitted>
  <study_first_submitted_qc>July 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2017</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Groningen</investigator_affiliation>
    <investigator_full_name>Johannes A. Langendijk</investigator_full_name>
    <investigator_title>Prof.Dr.</investigator_title>
  </responsible_party>
  <keyword>Breast cancer</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>Cardiac complications</keyword>
  <keyword>Acute coronary events</keyword>
  <keyword>NTCP model</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

